Agoracom: Small Cap Investment - Biomind Labs Inc - Discussion Forum

Biomind 300x300

The pharmaceutical side of psychedelics

Following strict scientific standards to protect patients and help produce reliable clinical trials results

Sponsored

List Message View

Thread Message View

Message Title

Rating

Author / Date

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 12% Vol: 2.2K Shares

Jan 23, 2023 04:00PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 18% On 2K Shares

Jan 11, 2023 04:20PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 33% On 2K Shares

Jan 04, 2023 04:20PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 36% On 3.2K Shares

Dec 30, 2022 04:20PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 20% On 2K Shares

Dec 29, 2022 04:20PM

Biomind Labs Announces the Completion of the First Sublingual Psychedelic Formulation for Its Drug Candidate BMND08 for Depression and Anxiety…

Dec 28, 2022 09:22AM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 14% On 14.5K Shares

Dec 20, 2022 04:20PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 20% On 5.4K Shares

Dec 02, 2022 04:20PM

Biomind Labs Announces FDA Investigational New Drug Clearance for Its New Chemical Entity Triptax™ Targeting Treatment-Resistant Depression...

Nov 14, 2022 09:13PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 21% On 2.4K Shares

Nov 10, 2022 04:20PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 30% On 3K Shares

Nov 04, 2022 04:20PM

Biomind Labs Announces Positive Initial Results From Its Phase II Trial on Its BMND01 Candidate for Treatment Resistant Depression

Nov 04, 2022 07:58AM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 60% On 1K Shares

Nov 02, 2022 04:20PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 47% On 1.1K Shares

Oct 21, 2022 04:20PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 49% On 1K Shares

Oct 11, 2022 04:20PM

Biomind Labs Announces Pre-IND Meeting Request Granted by FDA for Its New Chemical Entity Triptax™ Targeting Treatment-Resistant Depression

Oct 11, 2022 12:38PM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 17% On 2.7K Shares

Sep 28, 2022 04:20PM

Biomind Labs and Queen’s University of Belfast Receive Controlled Substances License to Commence the Production...

Sep 27, 2022 06:26AM

Biomind Labs Announces Completion of Dosing in Phase II Trial of Its DMT-Based Inhaled Formulation BMND01 for Treatment-Resistant Depression

Sep 21, 2022 06:25AM

END OF DAY ALERT: Biomind Labs (BMND: NEO) (BMNDF: OTC) Up 20% On 1.2K Shares

Sep 16, 2022 04:20PM